#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Anal cancer Fibrodysplasia ossificans progressiva Chronic hepatitis B Rheumatoid arthritis Neuronal ceroid lipofuscinosis Nodal marginal zone B-cell lymphoma KBG syndrome Complex regional pain syndrome Medullary thyroid cancer Glycogen storage disease type V Haemophilia B without inhibitors Systemic candida Uveal melanoma Neuroendocrine carcinoma of the skin Congenital growth hormone deficiency More trials…

    Learn about Rare Diseases

    Ewing’s sarcoma Ewing’s sarcoma – Diagnostics CADASIL – Basic Information Chondrosarcoma metastatic – Basic Information Optic glioma – Diagnostics Pituitary-dependent Cushing’s syndrome Rett syndrome – Basic Information Propionic acidaemia – Trials in Disease Mucopolysaccharidosis III – Trials in Disease Andersen-Tawil syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tiotropium Allo-647 SURVODUTIDE Dicloxacillin Emapalumab Betamethasone Gsk4527226 Ly3556050 Donepezil Hydrochloride Hydroxyzine Hydrochloride Acetazolamide Sodium Nitrogen Mk-4830 Peposertib Gr0015 Datopotamab Deruxtecan Azd9550 C1 Esterase Inhibitor (Human) Levobupivacaine LVT-001 More therapies…

    Learn about Your Condition

    Gastrointestinal melanoma Medulloblastoma Small intestine leiomyosarcoma Myocarditis post infection Pneumonia bacterial Fontan procedure Nodal osteoarthritis Pain in extremity Device related infection Carotid artery occlusion Oesophageal disorder Adenomatous polyposis coli Heparin resistance Dermatitis Head and neck cancer stage III More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Digestive System Diseases

  • Study on VE202 for Patients with Mild-to-Moderate Ulcerative Colitis

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Bacilli, Cluster Xviii, Strain Relative Thomasclavelia Ramosum, Live
    • Bacilli, Cluster Xviii, Strain Relative Thomasclavelia Sp000508865, Live
    • Clostridia, Cluster Iv, Strain Relative Anaerotruncus Colihominis, Live
    Bulgaria Czechia Hungary Lithuania The Netherlands Poland

  • Study of Pembrolizumab, Trastuzumab, and Drug Combination for Patients with HER2-Positive, Localized Esophagogastric Cancer

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Disodium Folinate
    • Docetaxel
    • Fluorouracil
    Germany

  • Study of Dasatinib and Quercetin combination for treating liver fibrosis in patients with Non-Alcoholic Fatty Liver Disease (NAFLD)

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Metabolic dysfunction-associated liver disease
    Investigated Drugs:
    • Quercetin
    • Cellulose, Microcrystalline
    • Dasatinib
    The Netherlands

  • Study on Norucholic Acid for Treating Primary Sclerosing Cholangitis in Patients

    Not recruiting

    3 1
    Investigated Diseases:
    • Cholangitis sclerosing
    Investigated Drugs:
    • Norucholic Acid
    Austria Denmark Finland France Germany Hungary +3

  • Study of SGM-101 Fluorescent Imaging for Detection of Early Rectal Cancer in Patients with Suspected T1 Adenocarcinoma or High-Grade Dysplasia

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Rectal cancer
    Investigated Drugs:
    • Chimeric Monoclonal Antibody Against Carcinoembryonic Antigen Conjugated To Fluorochrome Bm-104
    The Netherlands

  • Study of Tumor Treating Fields with Atezolizumab, Gemcitabine, and Nab-Paclitaxel for Patients with Metastatic Pancreatic Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma metastatic
    Investigated Drugs:
    • Atezolizumab
    Czechia Germany Spain
Previous Page
1 … 89 90 91 92 93
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!